18889881171
Kalkine 0
countryflagUS

AAPL 206.655 1.0044% MSFT 384.86 2.7965% NVDA 106.185 3.3833% GOOGL 158.72 2.1693% GOOG 160.73 1.9084% AMZN 185.5673 2.7504% META 530.91 2.0451% AVGO 187.43 5.9465% BRK-A 795500.0 0.8495% BRK-B 530.135 0.6312% LLY 855.05 3.0901% TSLA 255.535 1.9123% TSM 163.78 3.783% V 336.305 0.5787% JPM 243.935 1.2683% UNH 426.3 -0.3879% NVO 62.61 2.137% WMT 95.78 0.8635% LVMUY 113.69 1.6632% XOM 108.77 1.3039%

Advanced Proteome Therapeutics Corporation

Healthcare US APTCF

0.0002USD
-(-%)

Last update at 2025-04-23T20:00:00Z

Day Range

0.00020.0002
LowHigh

52 Week Range

0.00020.0002
LowHigh

Fundamentals

  • Previous Close 0.0002
  • Market Cap0.15M
  • Volume14313
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.92180M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM -0.00171M
  • Diluted EPS TTM-0.06

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-07-31 2021-07-31 2020-07-31 2019-07-31 2018-07-31
Type yearly yearly yearly yearly yearly
Date 2022-07-31 2021-07-31 2020-07-31 2019-07-31 2018-07-31
Income before tax 0.60M -1.92029M -0.54149M -0.46137M -0.89289M
Minority interest 0.16M 0.09M -1.67151M 0.13M 0.15M
Net income 0.76M -1.83456M -0.45064M -0.33347M -0.74477M
Selling general administrative 0.27M 0.67M 0.57M 0.92M 1.09M
Selling and marketing expenses - - - - -
Gross profit - - - -0.00171M -0.00010M
Reconciled depreciation 0.00464M 0.00290M 0.00324M 0.00418M 0.00583M
Ebit -0.95737M -0.67330M -0.56994M -0.92608M -1.09952M
Ebitda -0.95273M -0.67041M -0.56669M -0.92190M -1.09369M
Depreciation and amortization 0.00464M 0.00290M 0.00324M 0.00418M 0.00583M
Non operating income net other - - - - -
Operating income -0.95737M -0.67330M -0.56994M -0.92608M -1.09952M
Other operating expenses 0.96M 0.67M 0.57M 0.93M 1.10M
Interest expense 0.03M 0.03M 0.03M 0.02M 0.07M
Tax provision - - - - -
Interest income 0.00246M 0.00067M - - -
Net interest income -0.02664M -0.02674M -0.02953M -0.02296M -0.06985M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense -0.13304M -0.05832M -0.06133M -0.10494M -0.07826M
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 0.96M 0.67M 0.57M 0.93M 1.10M
Cost of revenue - - - 0.00171M 0.00010M
Total other income expense net 1.58M -1.21958M 0.06M 0.49M 0.28M
Discontinued operations - - - - 0.00000M
Net income from continuing ops 0.60M -1.92029M -0.54149M -0.46137M -0.89289M
Net income applicable to common shares 0.76M -1.83456M -0.45064M -0.33347M -0.74477M
Preferred stock and other adjustments - - - - -
Breakdown 2022-07-31 2021-07-31 2020-07-31 2019-07-31 2018-07-31
Type yearly yearly yearly yearly yearly
Date 2022-07-31 2021-07-31 2020-07-31 2019-07-31 2018-07-31
Total assets 0.64M 0.90M 0.02M 0.17M 0.18M
Intangible assets - - - - 0.00000M
Earning assets - - - - -
Other current assets 0.00500M 0.00500M 0.00500M 0.00667M 0.00667M
Total liab 1.49M 2.96M 1.40M 1.08M 1.08M
Total stockholder equity 1.07M -0.30191M 0.29M 0.67M 0.56M
Deferred long term liab - - - - 0.00000M
Other current liab 0.48M 0.27M 0.19M 0.17M 0.15M
Common stock 20.20M 19.88M 18.81M 18.76M 18.41M
Capital stock 20.20M 19.88M 18.81M 18.76M 18.41M
Retained earnings -22.30561M -23.06522M -21.23067M -20.78003M -20.44656M
Other liab 0.02M 1.79M 0.26M 0.11M 0.41M
Good will - - - - 0.00000M
Other assets - - - - 0.00000M
Cash 0.54M 0.82M 0.00243M 0.13M 0.14M
Cash and equivalents - - - - -
Total current liabilities 1.24M 1.00M 0.99M 0.84M 0.67M
Current deferred revenue - - - - -
Net debt -0.21266M -0.49748M 0.29M 0.06M -0.08237M
Short term debt 0.10M 0.15M 0.15M 0.06M 0.05M
Short long term debt 0.10M 0.15M 0.15M 0.06M 0.05M
Short long term debt total 0.33M 0.32M 0.30M 0.19M 0.05M
Other stockholder equity 0.28M 2.89M 2.71M 2.68M 2.60M
Property plant equipment 0.02M 0.00639M 0.00757M 0.01M 0.01M
Total current assets 0.62M 0.89M 0.01M 0.16M 0.17M
Long term investments - - - - 0.00000M
Net tangible assets 1.07M -0.30191M 0.29M 0.67M 0.56M
Short term investments - - - - 0.00000M
Net receivables 0.05M 0.05M - - -
Long term debt 0.23M 0.17M 0.15M 0.14M 0.00000M
Inventory - - - - 0.00000M
Accounts payable 0.67M 0.58M 0.65M 0.61M 0.46M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income 2.90M 2.89M 2.71M 2.68M 2.60M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.02M 0.00639M 0.00757M 0.01M 0.01M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-07-31 2021-07-31 2020-07-31 2019-07-31 2018-07-31
Type yearly yearly yearly yearly yearly
Date 2022-07-31 2021-07-31 2020-07-31 2019-07-31 2018-07-31
Investments -0.01379M -0.04986M 0.00000M -0.00139M 0.00000M
Change to liabilities 0.09M -0.07150M 0.04M 0.14M -0.07617M
Total cashflows from investing activities -0.01379M -0.04986M -0.04986M -0.00139M -0.00139M
Net borrowings - 0.05M 0.09M 0.14M -0.05089M
Total cash from financing activities 0.43M 1.41M 0.34M 0.68M 1.21M
Change to operating activities 0.22M 0.08M 0.03M 0.02M -0.05519M
Net income 0.60M -1.92029M -0.54149M -0.46137M -0.89289M
Change in cash -0.27793M 0.82M -0.12955M -0.00374M -0.00232M
Begin period cash flow 0.82M 0.00243M 0.13M 0.14M 0.14M
End period cash flow 0.54M 0.82M 0.00243M 0.13M 0.14M
Total cash from operating activities -0.69358M -0.54520M -0.46698M -0.68570M -1.21231M
Issuance of capital stock 0.15M 1.37M 0.25M 0.55M -
Depreciation 0.00464M 0.00290M 0.00324M 0.00418M 0.00583M
Other cashflows from investing activities - -0.04814M -0.04814M -0.04814M -0.04814M
Dividends paid - - - - 0.00000M
Change to inventory - - - - 0.00000M
Change to account receivables - - - - 0.00000M
Sale purchase of stock - - - - 0.00000M
Other cashflows from financing activities 0.28M 0.05M 0.09M 0.14M 0.00000M
Change to netincome -1.75897M 1.27M -0.08951M -0.52724M -0.41159M
Capital expenditures 0.01M 0.00172M 0.00172M 0.00139M 0.00139M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.30M -0.01319M 0.07M 0.16M -0.13136M
Stock based compensation 0.00000M 0.13M 0.03M 0.08M 0.10M
Other non cash items -1.59684M 1.25M -0.02677M -0.47004M -0.29493M
Free cash flow -0.70737M -0.54692M -0.46698M -0.68710M -1.21231M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
APTCF
Advanced Proteome Therapeutics Corporation		 - -% 0.0002 - - - 4.22 -6.3806
NVO
Novo Nordisk A/S		 1.31 2.14% 62.61 41.58 31.15 2.13 32.99 2.11 4.70
NONOF
Novo Nordisk A/S		 1.30 2.09% 63.55 41.06 31.25 2.08 33.11 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 -1.42 0.29% 491.00 29.67 24.33 10.38 5.83 9.33 20.00
REGN
Regeneron Pharmaceuticals Inc		 2.92 0.50% 590.76 29.07 20.12 7.57 3.82 6.95 19.42

Reports Covered

Stock Research & News

View All

Profile

Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.

Advanced Proteome Therapeutics Corporation

8337 Eastlake Drive, Burnaby, BC, Canada, V5A 4W2

Key Executives

Name Title Year Born
Mr. Paul John Courtney Woodward Pres, CEO, Director & Member of Corp. Advisory Board 1962
Mr. Kenneth Clifford Phillippe C.A., B.Com., B.Comm, CPA, CA, CPA Chief Financial Officer 1952
Mr. Martin John Courtney Woodward Sec. & Independent Director 1968
Mr. Kenneth Clifford Phillippe B.Comm, CA, CPA Chief Financial Officer 1952
Mr. Martin John Courtney Woodward Secretary & Independent Director 1968
Dr. Benjamin Krantz M.B.A., M.D. President, CEO & Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.